–{•¶‚ÖƒXƒLƒbƒv

‰ªŽR‘åŠw–òŠw•”^‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘‡Œ¤‹†‰È

TEL. 086-252-1111

§700-8530 ‰ªŽRŒ§‰ªŽRŽs–k‹æ’Ó‡’†1’š–Ú1”Ô1†
>English

Šw‰ï”­•\CONFERENCE PRESENTATION

y•½¬26”N“xz

193) ›ŽR–{—ÈCbŒ³‘åŽ÷CŽR‰ºŒ÷—SC•è—E“ñF
‰t’†•ªŽUŒ^ŠO—p܂̉”\«FIn vitro”畆“§‰ß“Á«‚Ì•]‰¿.
‘æ53‰ñ“ú–{–òŠw‰ïE“ú–{–òÜŽt‰ïE“ú–{•a‰@–òÜŽt‰ï’†‘Žl‘Žx•”Šwp‘å‰ïCL“‡ŽsC11.8-9, 2014.

192) ›Yuji Kurosaki, Tsutomu Hatano, Mitsunobu Kano, Hironori Nakura, Hye-Sook Kim and Yoshinori Moriyama:
Education at Faculty of Pharmaceutical Sciences Okayama University (Japan).
3rd Pharmacy Deans Forum 2014 (Asian Association of Schools of Pharmacy), Tokyo, 6.28-29, 2014.

191) ›ŠFì‹M²AèŽR’B–îA•ú±—E“ñ:
In vitro‰ñŽû“®‘Ô‚ðd‚ÝŠÖ”‚Æ‚·‚é”÷¬“§Í–@‚É‚¨‚¯‚郂ƒjƒ^’x‚ê‚Ì•â³.
“ú–{–òÜŠw‰ï‘æ29”N‰ïC‚³‚¢‚½‚ÜŽsC5.20-22, 2014.

190) ›“n•Ó‘PÆA•è—E“ñA‚‹´KˆêA’|“à—m•¶:
–òÜŠw‹³ˆç‚É‚¨‚¯‚é‘Û«‚Ì[ŽÀ‚ÉŒü‚¯‚Ä.
“ú–{–òÜŠw‰ï‘æ29”N‰ïC–òŠw‹³ˆçƒVƒ“ƒ|ƒWƒEƒ€C‚³‚¢‚½‚ÜŽsC5.20-22, 2014.



y•½¬25”N“xz

189) ›‹à@œ¨iA’†‘º—RA‰Í–{—¹A•Ð–{@ˆ©A²“¡@‘AžwŠ_˜aFA•è—E“ñA–È–î—L—CF
”ñŒoŒûŒ^Rƒ}ƒ‰ƒŠƒA–ò‚ÌŠJ”­Œ¤‹†.
“ú–{–òŠw‰ï‘æ134”N‰ïCŒF–{ŽsC3.27-30, 2014.

188) ›Aya Yoshii, Fusako Takayama, Yasumasa Kodo, Ritsuko Watanabe, Hiroshi Toyoda, Mitsumasa Mankura, Toru Egashira, Hideaki Kabuto, Tomoko Yamanushi, Yuji Kurosaki, Shigeru Okada and Akitane Mori:
Mechanism of spirulina platensis efficacy against non-alcoholic steatoepatitis model rats.
17th Meeting of Society for Free Radical Research (SFRR) International 2014, Kyoto, Japan, 3.23-26, 2014.

187) ›‚‹´@•‘AbŒ³‘åŽ÷AŽR‰ºŒ÷—SA•è—E“ñF
‘¬“x˜_‚ÉŠî‚­»ÜÝŒv‚ÌÅ“K‰»FƒCƒk‚É‚¨‚¯‚éƒAƒ€ƒƒWƒsƒ“ŒJ‚è•Ô‚µ“Š—^Žž‚ÌŒŒ’†”Z“x—\‘ª.
‘æ34‰ñ“®•¨—Õ°ˆãŠw‰ï”NŽŸ‘å‰ïC‘åãŽsC11.15-17C2013.

186) ›Yuji Kurosaki, Yukio Sugimoto, Hye-Sook Kim and Mitsunobu Kano:
A new international project (MURRPES) to share advanced pharmaceutical education systems in Japan and Korea in a new era proposed by Okayama Univesity, Japan.
6th Asian Association of Schools of Pharmacy Conference, Singapore, 11.14-17, 2013.

185) ›èŽR’B–îAŠFì‹M²A•è—E“ñF
”÷¬“§Í–@‚ð‰ž—p‚µ‚½‹ÇŠ–ò•¨“®‘Ô•]‰¿F“¯ŽžŸó—¬Zero-net-flux–@‚̉”\«.
‘æ52‰ñ“ú–{–òŠw‰ïE“ú–{–òÜŽt‰ïE“ú–{•a‰@–òÜŽt‰ï’†‘Žl‘Žx•”Šwp‘å‰ïC¼ŽRŽsC10.26-27, 2013.

184) ›‰F“s–ì˜ÐŽjA–q”V’iŒhˆêA’·‰i~ŽjA‡—t“N–çA•ú±—E“ñF
—V—£Œ`–ò•¨”Z“xƒ‚ƒjƒ^‚ÉŠî‚­‹Ø“÷“à‹ÇŠ—˜—p—¦‚Ì•]‰¿F‹ÇŠ—â‹pŽž‚Ìin vivoŠgŽUƒ‚ƒfƒ‹‚É‚æ‚é”—“I‰ðÍ.
“ú–{–òÜŠw‰ï‘æ28”N‰ïC–¼ŒÃ‰®ŽsC5.23-25, 2013.



y•½¬24”N“xz

183) ›“y‹‰ë”üAŠì“TŽqA‘êˆêA•è—E“ñA‡—t “N–çF
‹}«‹ÇŠ‰ŠÇ‚É”º‚¤–ò•¨ŠÌ‘ãŽÓŠˆ«‚Ì•Ï“®ƒƒJƒjƒYƒ€‚ÌŒŸ“¢.
“ú–{–òŠw‰ï‘æ133”N‰ïC‰¡•lŽsC3.27-30, 2013.

182) ›Atsushi Osanaga, Keiichi Makinodan, Tatsuya Sakiyama, Tetsuya Aiba and Yuji Kurosaki:
Evaluation of dynamic diffusion process for developing focally acting DDSs: Improvement of focal bioavailability by topical cooling.
‘æ6‰ñŽŸ¢‘ã‚ð’S‚¤ŽáŽèˆã—Öò‰ÈŠwƒVƒ“ƒ|ƒWƒEƒ€C‹ž“sŽsC11.23-24, 2012.

181) ›Yukiko Takahata, Risa Takaki, Mizuki Horiuchi, Soichiro Moriyama, Tetsuya Aiba and Yuji Kurosaki:
Effect of intraperitoneal lipid emulsions on plasma-to-peritoneal transfer of lipophilic drugs in rats.
“ú–{–ò•¨“®‘ÔŠw‰ï‘æ27‰ñ”N‰ïC“Œ‹žC11.20-22, 2012.

180) ›Noriko Kajikawa, Masami Doi, Jun-ichi Kusaba, Yuji Kurosaki and Tetsuya Aiba:
Effects of acute local inflammation on the hepatic expressions of the CYP3A subfamily in rats.
“ú–{–ò•¨“®‘ÔŠw‰ï‘æ27‰ñ”N‰ïC“Œ‹žC11.20-22, 2012.

179) ›‚–Ø—ŽÑA‚”¨—F‹IŽqA–x“àŽ÷AXŽR‘ˆê˜YA‡—t “N–çA•è —E“ñF
• o“à‚É’“ü‚µ‚½Ž‰–b“ûÜ‚ªŒŒŸ÷’†‹y‚Ñ• o“à–ò•¨“®‘Ô‚É‹y‚Ú‚·‰e‹¿FŽ‰—n«‚̈قȂé–ò•¨‚Å‚Ì”äŠrŒŸ“¢.
‘æ51‰ñ“ú–{–òŠw‰ïE“ú–{–òÜŽt‰ïE“ú–{•a‰@–òÜŽt‰ï’†‘Žl‘Žx•”Šwp‘å‰ïC¼]ŽsC11.10-11, 2012.

178) ›“y‹‰ë”üAŠì“TŽqA‘êˆêA•è—E“ñA‡—t “N–çF
ƒ‰ƒbƒgŠÌCYP3A‘ãŽÓŠˆ«‚É‹y‚Ú‚·‹}«‹ÇŠ‰ŠÇ‚̉e‹¿.
‘æ51‰ñ“ú–{–òŠw‰ïE“ú–{–òÜŽt‰ïE“ú–{•a‰@–òÜŽt‰ï’†‘Žl‘Žx•”Šwp‘å‰ïC¼]ŽsC11.10-11, 2012.

177) ›–q”V’i ŒhˆêA“Œ‰¶”[ ŽiAèŽR ’B–îA‡—t “N–çA•è —E“ñF
Microdialysis–@‚ð—p‚¢‚½–ò•¨‚Ì‹Ø“÷“à‹ÇŠ“®‘Ô•]‰¿:‹ÇŠ—â‹p‚É‚æ‚é‹ÇŠ–ò•¨—˜—p—¦‚Ì‘‘å.
‘æ28‰ñ“ú–{DDSŠw‰ïŠwpW‰ïCŽD–yŽsC7. 4-5, 2012.

176) ›¬ì@“ÖA X@‘×—TA ‚‹´@•‘A ‡—t“N–çA •è—E“ñF
Ž¼—Ö@—p”í•¢Œ^ŠO—pŠîÜ‚Æ‚µ‚Ä‚ÌL-HPCŠÜ…ƒQƒ‹ƒV[ƒg‚̻ܓI“Á«•]‰¿.
“ú–{–òÜŠw‰ï‘æ27”N‰ïC_ŒËŽsC5.24-26, 2012.

175) ›Œã“¡—SŽqA ‘C“c‚ ‚ä‚ÝA •ú±—E“ñA ‡—t“N–çF
ƒ‰ƒbƒg‚É‚¨‚¯‚éƒLƒgƒTƒ“‚ð—p‚¢‚½“ï‹zŽû«RƒEƒBƒ‹ƒX–ò‚ÌÁ‰»ŠÇ‹zŽû‰ü‘P.
“ú–{–òÜŠw‰ï‘æ27”N‰ïC_ŒËŽsC5.24-26, 2012.

174) ›èŽR’B•vA‰ª ‘åŽkAƒg[ƒ}ƒXEƒWƒFƒŠƒ}ƒ„A‡—t“N–çA•ú±—E“ñF
Ž‰–b“ûÜ”÷¬“§Í–@iLipo-MD–@j‚É‚æ‚ée–û«–ò•¨‚Ì‹ÇŠ“®‘Ôƒ‚ƒjƒ^“Á«‚̉ü‘P.
“ú–{–òÜŠw‰ï‘æ27”N‰ïC_ŒËŽsC5.24-26, 2012.


y•½¬23”N“xz

173) ›‰ª“c~–FC‰Í–쌒‘¾˜YCÎ쉷ŽqCâ]—˜ŒbC‡—t“N–çCìú±”ŽŒÈC•è—E“ñF
ƒ‰ƒbƒg”]Ò‘‰t‚Ì“d‰ðŽ¿•½t’²ß‹@\‚É‹y‚Ú‚·‹}«‰ŠÇ‚̉e‹¿.
“ú–{–òŠw‰ï‘æ132”N‰ïCŽD–yŽsC3.28-31, 2012.

172) ›‡—t“N–çC‘ºã—RŽ÷C´…N³Cì“c_•½C’†ŽR^—ŽqC¬Š}Œ´–¾”üC‰ª“c~–FC•è—E“ñC‰Á—ˆ“c”Ž‹MF
V‹KRXRƒAƒSƒjƒXƒg‹y‚Ñ‚»‚Ì—Þ‰‰»‡•¨‚̃qƒgŠÌ‚É‚¨‚¯‚é‘ãŽÓ“Á«‚Ì—\‘ª.
“ú–{–òŠw‰ï‘æ132”N‰ïCŽD–yŽsC3.28-31, 2012.

171) ›•è—E“ñF
ƒgƒ‰ƒCƒAƒ‹•]‰¿‚ÌŠT—vF‘—§‘åŠw‚Ì—§ê‚©‚ç.iˆê”ʃVƒ“ƒ|ƒWƒEƒ€u‚U”N§–òŠw‹³ˆçƒvƒƒOƒ‰ƒ€‚Ì‘æŽOŽÒ•]‰¿`ƒgƒ‰ƒCƒAƒ‹‚©‚ç–{•]‰¿‚Ö`vCƒgƒ‰ƒCƒAƒ‹•]‰¿‚ÌŠT—vj
“ú–{–òŠw‰ï‘æ132”N‰ïCŽD–yŽsC3.28-31, 2012.

170) ›Kentaro Kono, Atsuyoshi Okada, Atsuko Ishikawa, Rie Sakae, Hiromu Kawasaki, Yuji Kurosaki and Tetsuya Aiba:
Effect of acute inflammation on lithium disposition to cerebrospinal fluid in rats
“ú–{–ò•¨“®‘ÔŠw‰ï‘æ26‰ñ”N‰ïCL“‡ŽsC11.16-18, 2011.

169) ›Yoshiki Murakami, Yasumasa Shimizu, Kohei Kawata, Mariko Nakayama, Akemi Ogasawara, Yuji Kurosaki, Tetsuya Aiba and Hirotaka Kakuta:
Metabolic properties of novel retinoid X receptor agonists possessing various side chain structures in liver microsomes
“ú–{–ò•¨“®‘ÔŠw‰ï‘æ26‰ñ”N‰ïCL“‡ŽsC11.16-18, 2011.

168) ›Mahira Hashim, Hiroyuki Miyachi, Thomas Jeremiah, Tetsuya Aiba and Yuji Kurosaki:
Studies on the biopharmaceutical characteristics of novel PPAR pan-agonist, TIPP-703, and its pharmaceutical modification to improve intestinal absorption.
“ú–{–ò•¨“®‘ÔŠw‰ï‘æ26‰ñ”N‰ïCL“‡ŽsC11.16-18, 2011.

167) ›‰ª“c~–FA‰Í–쌒‘¾˜YAÎ쉷ŽqAâ]—˜ŒbAìú±”ŽŒÈA•ú±—E“ñA‡—t“N–çF
‹}«‰ŠÇ‚É”º‚¤“d‰ðŽ¿‚Ì”]Ò‘‰tˆÚs“Á«‚Ì•Ï“®•]‰¿.
‘æ50‰ñ“ú–{–òŠw‰ïE“ú–{–òÜŽt‰ïE“ú–{•a‰@–òÜŽt‰ï’†‘Žl‘Žx•”Šwp‘å‰ïC‚¼ŽsC11.12-13, 2011.

166) ›´…N³A‘ºã—RŽ÷Aì“c_•½A’†ŽR^—ŽqA¬Š}Œ´–¾”üA•ú±—E“ñA‡—t“N–çA‰Á—ˆ“c”Ž‹MF
V‹KœŠi‚ð—L‚·‚éRXRƒAƒSƒjƒXƒg‚Ì‘¤½\‘¢‚ÆŠÌ‘ãŽÓŠˆ«‚Ì‘ŠŠÖ‰ðÍ.
‘æ50‰ñ“ú–{–òŠw‰ïE“ú–{–òÜŽt‰ïE“ú–{•a‰@–òÜŽt‰ï’†‘Žl‘Žx•”Šwp‘å‰ïC‚¼ŽsC11.12-13, 2011.

165) ›‚”¨—F‹IŽqA–x“àŽ÷AXŽR‘ˆê˜YA‡—t“N–çA•è—E“ñF
• o“à\‘SgzŠÂŒŒŠÔ‚Ì–ò•¨ˆÚs“®‘Ô‚É‹y‚Ú‚·Ž‰–b“û܂̉e‹¿F• o“à“Š—^Žž‚̈Ús“®‘Ô.
‘æ21‰ñ“ú–{ˆã—ÖòŠw‰ï”N‰ïC_ŒËC10.1-2, 2011.

164) ›X‘×—TA¬ì“ÖA‚‹´•‘AXŽR‘ˆê˜YA㌴–ƒ–¢A’†ŽRË]A‡—t“N–çA•è—E“ñF
L-HPCŠÜ…ƒQƒ‹ƒV[ƒg‚ÌŽ¼—Ö@—p”í•¢Œ^ŠO—pŠîÜ‚Æ‚µ‚Ă̻ܓI“Á«.
‘æ21‰ñ“ú–{ˆã—ÖòŠw‰ï”N‰ïC_ŒËC10.1-2, 2011.

163) ›‚‹´KˆêA“n•Ó‘PÆA•ú±—E“ñA’|“à—m•¶F
‹³ˆç•ª‰È‰ï‚©‚ç‚Ì’ñŒ¾.
“ú–{–òÜŠw‰ï‘æ26”N‰ïi–òŠw‹³ˆçƒVƒ“ƒ|ƒWƒEƒ€u–òŠw•”‹³ˆç‚É‘±‚­V‘åŠw‰@‰Û’ö‚Å‚Ì‹³ˆç‚ÆŒ¤‹†FŠî‘b‚Æ‚µ‚Ä‚ÌŠw•”‹³ˆç‚©‚çV¶‘åŠw‰@‹³ˆç‚ÖvjC“Œ‹žC5.29-31, 2011.

162) ›–q”V’iŒhˆêA“Œ‰¶”[@ŽiA‘ºãm”üA‡—t“N–çA•ú±—E“ñF
–ò•¨‚Ì‹Ø“÷“àŠgŽUE•ª•z“®‘Ô‚É‹y‚Ú‚·ŒŒ—¬—ʂ̉e‹¿F‹ÇŠ—â‹pŽž‚Ì“®‘Ô“Á«.
“ú–{–òÜŠw‰ï‘æ26”N‰ïC“Œ‹žC5.29-31, 2011.

@@@@@

y•½¬22”N“xz

161) ›•ú±—E“ñA•x‰ª‰À‹vAŽO“c’q•¶A–k‘º‰À‹vF
‘—§‘åŠw‚É‚¨‚¯‚éu’·Šú‰Û‘茤‹†‹y‚уAƒhƒoƒ“ƒXƒg‹³ˆçƒvƒƒOƒ‰ƒ€v‚ÌŒ»ó.
“ú–{–òŠw‰ï‘æ131”N‰ïiƒVƒ“ƒ|ƒWƒEƒ€u擱“I–òÜŽt—{¬‚ÉŒü‚¯‚½ŽÀ‘H“IƒAƒhƒoƒ“ƒXƒg‹³ˆçƒvƒƒOƒ‰ƒ€‚Ì‹¤“¯ŠJ”­vjCɪŽsC3.28-31, 2011.

160) ›Šì“TŽqA‘êˆêAo‰H—SŠîA‡—t“N–çAì蔎ŒÈA•ú±—E“ñF
ƒ‰ƒbƒg‚É‚¨‚¯‚é–ò•¨ŠÌ‘ãŽÓy‘f‚Ì”­Œ»‚É‹y‚Ú‚·‹}«t•s‘S‚̉e‹¿.
“ú–{–òŠw‰ï‘æ131”N‰ïCɪŽsC3.28-31, 2011.

159) ›Œã“¡—SŽqA‘C“c‚ ‚ä‚ÝA‡—t“N–çA•ú±—E“ñF
ƒ‰ƒbƒg‚É‚¨‚¯‚éƒLƒgƒTƒ“‚̃AƒVƒNƒƒrƒ‹Á‰»ŠÇ‹zŽû‘£i‹@\‚ÌŒŸ“¢.
“ú–{–òŠw‰ï‘æ131”N‰ïCɪŽsC3.28-31, 2011.

158) ›Šì“TŽqA‘êˆêAo‰H—SŠîA‡—t“N–çAì蔎ŒÈA•ú±—E“ñF
ƒ‰ƒbƒg‚É‚¨‚¯‚é–ò•¨ŠÌ‘ãŽÓŠˆ«‚É‹y‚Ú‚·‹}«t•s‘S‚̉e‹¿.
‘æ49‰ñ“ú–{–òŠw‰ïE“ú–{–òÜŽt‰ïE“ú–{•a‰@–òÜŽt‰ï’†‘Žl‘Žx•”Šwp‘å‰ïC•ÄŽqŽsC11.6-7, 2010.

157) ›‰ª@‘åŽkA¬—Ñ@“OA‡—t“N–çA•ú±—E“ñF
Ž‰–b“ûÜ‚ð—p‚¢‚½”÷¬“§Í–@iLipo-MD–@jF–ò•¨‚ÌŽ‰—n«‚ª“§Í“Á«‚É‹y‚Ú‚·‰e‹¿.
‘æ49‰ñ“ú–{–òŠw‰ïE“ú–{–òÜŽt‰ïE“ú–{•a‰@–òÜŽt‰ï’†‘Žl‘Žx•”Šwp‘å‰ïC•ÄŽqŽsC11.6-7, 2010.

156) ›‚”¨—F‹IŽqAXŽR‘ˆê˜YA–x“àŽ÷A‡—t“N–çA•ú±—E“ñF
Ž‰–b“ûÜ‚ð—p‚¢‚½• –Œ“§Í‚ªŽ‰—n«–ò•¨‚ÌŒŒŸ÷’†”Z“x„ˆÚ‚É‹y‚Ú‚·‰e‹¿.
‘æ49‰ñ“ú–{–òŠw‰ïE“ú–{–òÜŽt‰ïE“ú–{•a‰@–òÜŽt‰ï’†‘Žl‘Žx•”Šwp‘å‰ïC•ÄŽqŽsC11.6-7, 2010.

155) ›Œã“¡—SŽqA‘C“c‚ ‚ä‚ÝA‡—t“N–çA•ú±—E“ñF
In vivo‚É‚¨‚¯‚éƒLƒgƒTƒ“‚̃AƒVƒNƒƒrƒ‹‹zŽû‘£i‹@\‚ÌŒŸ“¢.
‘æ49‰ñ“ú–{–òŠw‰ïE“ú–{–òÜŽt‰ïE“ú–{•a‰@–òÜŽt‰ï’†‘Žl‘Žx•”Šwp‘å‰ïC•ÄŽqŽsC11.6-7, 2010.

154) ›Jun-ichi Kusaba, Noriko Kajikawa, Yuki Izuwa, Tetsuya Aiba, Hiromu Kawasaki and Yuji Kurosaki:
Altered drug metabolizing activity of hepatic CYP3A subfamily in rats with acute renal failure.
“ú–{–ò•¨“®‘ÔŠw‰ï‘æ25‰ñ”N‰ïC“Œ‹žC10.7-9, 2010.

153) ›Tsukasa Higashionna, Hitomi Murakami, Keiichi Makinodan, Kozue Kanda, Mayu Shibata, Tetsuya Aiba and Yuji Kurosaki:
Microdialysis study in evaluation of intramuscular lateral distribution profiles of topically administered drugs in rats.
“ú–{–ò•¨“®‘ÔŠw‰ï‘æ25‰ñ”N‰ïC“Œ‹žC10.7-9, 2010.

152) ›ê “c’ŽuA㓇 ’qA²“¡’qºA‡—t“N–çA•è—E“ñA¼‰i ®Aç“°”NºF
¬Ž™‚É‚¨‚¯‚éƒeƒCƒRƒvƒ‰ƒjƒ“‚Ì•êW’c–ò•¨“®‘Ô‰ðÍ|ŒŒ’†”Z“x‚É‹y‚Ú‚·Šî‘bŽ¾Š³‚̉e‹¿|.
‘æ27‰ñ“ú–{‚s‚c‚lŠw‰ïEŠwp‘å‰ïCŽD–yŽsC6.26-27, 2010.

151) ›X@‘×—TAXŽR‘ˆê˜YA㌴–ƒ–¢A’†ŽRË]A‡—t“N–çA•ú±—E“ñF
L-HPCŠÜ…ƒQƒ‹ƒV[ƒg‚Ì’²»‚Ɣ핢Œ^ŠO—pŠîÜ‚Æ‚µ‚Ă̻ܓI“Á«•]‰¿.
“ú–{–òÜŠw‰ï‘æ25”N‰ïC“¿“‡ŽsC5.12-14, 2010.

150) ›‘C“c‚ ‚ä‚ÝA‡—t“N–çA•ú±—E“ñF
In vivo‚É‚¨‚¯‚é“ï‹zŽû«RƒEƒBƒ‹ƒX–ò‚̃oƒCƒIƒAƒxƒCƒ‰ƒrƒŠƒeƒB‰ü‘P‚ÌŽŽ‚Ý.
“ú–{–òÜŠw‰ï‘æ25”N‰ïC“¿“‡ŽsC5.12-14, 2010.

»ÜÝŒv•]‰¿Šw

§700-8530
‰ªŽRŒ§‰ªŽRŽs–k‹æ’Ó‡’†1’š–Ú1”Ô1†

TEL 086-252-1111